|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.6 USD | -1.38% |
|
-4.71% | -8.82% |
| May. 22 | Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies | RE |
| May. 20 | Goldman Sachs Adjusts Kenvue Price Target to $21 From $20 | MT |
May 13 (Reuters) - Johnson & Johnson will sell all its 182.3 million shares in its spun-off company Kenvue in a stock offering in a debt-for-equity exchange, the consumer health product firm said in a filing on Monday. (Reporting by Leroy Leo in Bengaluru; Editing by Shilpi Majumdar)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 150.4 USD | -2.00% | -2.52% | 369B | ||
| 19.66 USD | -1.08% | -4.25% | 38.07B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -8.38% | 38.07B | |
| +13.80% | 396B | |
| +13.47% | 136B | |
| +18.44% | 77.74B | |
| -10.61% | 66.79B | |
| -12.47% | 46.89B | |
| +7.81% | 35.65B | |
| +10.88% | 18.19B | |
| +16.69% | 16.04B | |
| +0.49% | 11.79B |
KENVUE INC. 
